CD4 and AIDS: These results are supported by the fact that individuals who start ART with CD4+ T cell baseline ≥500 cells/μL have a decreased risk of AIDS progression and a higher probability of maintaining viral suppression for a long time and achieving adequate immunological recovery when compared to those with pre-CD4+ T cell counts ≤200 cells/μL [30,31,32,33].